Study of a new system for treating ventricular tachycardia
Part of Heart & circulation clinical trials.
This study tests a new device called the DuoVT PFA System to treat ventricular tachycardia, a fast heart rhythm that can be dangerous. It aims to help people who have this condition along with heart disease from a past heart attack, and who have not been helped by medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart attack in the past
- You have had at least one episode of a fast, regular heart rhythm called sustained monomorphic ventricular tachycardia in the last 6 months
- This fast rhythm came back even after taking antiarrhythmic drugs, or you cannot take these drugs
- You have an implanted defibrillator (ICD or CRT-D) placed at least 30 days before the procedure
- You are between 18 and 80 years old and are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This trial tests a new type of energy (pulsed field ablation) to treat a fast heart rhythm called ventricular tachycardia that happens after a heart attack. The goal is to stop the dangerous rhythm without damaging nearby healthy tissue.
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
This trial tests two different ways of mapping the heart to guide treatment for a dangerous fast heart rhythm. The goal is to see which mapping method works better for people with an ICD who need a procedure called ablation to stop the rhythm.
This study tests a new method using two types of energy to treat a fast heartbeat coming from the lower heart chambers. It is designed for people whose symptoms have not been controlled by medication and who do not have other serious heart conditions.
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.